539730 — Fredun Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹3.95bn
- IN₹5.55bn
- IN₹4.54bn
- 51
- 38
- 64
- 52
Annual cashflow statement for Fredun Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 20.1 | 63.1 | 108 | 156 | 200 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 20.5 | 32 | 39 | 185 | 297 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -63.3 | -141 | -343 | -387 | -838 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.7 | -23.8 | -144 | -4.39 | -291 |
| Capital Expenditures | -13.9 | -42.7 | -94.9 | -76.4 | -61.1 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 1.43 | 0.901 | — | -2.48 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -13.9 | -41.3 | -94 | -76.4 | -63.5 |
| Financing Cash Flow Items | -54.6 | -56.6 | -88.9 | -130 | -226 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -7.13 | 74.7 | 252 | 59.9 | 391 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -19.3 | 9.57 | 13.6 | -20.8 | 37 |